Vol 2023, No 12 (2023)

Table of Contents

Research & Development

Bristol Myers Squibb Signs Licensing Deal with Avidity Biosciences for Multiple Cardiovascular Targets Abstract pdf html
Shweta Gupta

Licensing

Merck KGaA Signs Licensing Agreement with Abbisko for Pimicotinib Abstract pdf html
Lalit Mishra

Mergers & Acquisitions

AbbVie to Acquire ImmunoGen for US$10.1 B Abstract pdf html
Lucy Haggerty
AbbVie to Buy Cerevel Therapeutics for US$8.7 B to Bolster Neuroscience Portfolio Abstract pdf html
Lucy Haggerty
Roche to Acquire Carmot Therapeutics for US$3.1 B Abstract pdf html
Ayush Saxena


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.